Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $33.78 USD
Change Today -0.83 / -2.40%
Volume 494.5K
ACOR On Other Exchanges
As of 4:30 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jane Wasman J.D.

President of International, General Counsel and Corporate Secretary, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Ms. Jane Wasman, J.D., has been General Counsel and Corporate Secretary of Acorda Therapeutics since July 2004 and its President of International since October 09, 2012. Ms. Wasman served as the Chief of Strategic Development of Acorda Therapeutics, Inc. since February 2012. She has also been Executive Vice President of Acorda Therapeutics since July 2004. She served as Staff Vice President and Associate General Counsel at Schering-Plough Corporation, supporting U.S. ...

Read Full Background

Corporate Headquarters*

420 Saw Mill River Road
Ardsley, New York 10502

United States

Phone: 914-347-4300
Fax: 914-347-4560

Board Members Memberships*

Member of the Board of Directors


Bachelor's Degree
Princeton University
Harvard Law School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$555,492

Stock Options*

Restricted Stock Awards$324,885
All Other Compensation$7,650
Exercised Options44,769
Exercised Options Value$1,185,365
Exercisable Options365,171
Unexercisable Options128,697
Total Value of Options$1,185,365
Total Number of Options538,637

Total Compensation*

Total Annual Cash Compensation$917,814
Total Short Term Compensation$555,492
Other Long Term Compensation$332,535
Total Calculated Compensation$2,334,282
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $33.78 USD -0.83


James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Stephen R. Davis J.D.Interim Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Executive Vice President
ACADIA Pharmaceuticals Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at